SERENATIS BIO LIMITED

15944501
Active Cambridge

Research and experimental development on biotechnology

2 employees website.com
Research and experimental development on biotechnology
S

SERENATIS BIO LIMITED

15944501

Research and experimental development on biotechnology

Founded 9 Sept 2024 Active Cambridge, England 2 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 3 Dec 2025 Next due 30 Jun 2027 12 months remaining
Confirmation Submitted 9 Sept 2025 Next due 22 Sept 2026 3 months remaining
Net assets £782K
Total assets £816K
Total Liabilities £34K
Charges None No charges registered

Contact & Details

Contact

Registered Address

66 Devonshire Road Cambridge CB1 2BL England

Website

www.example.com

Full company profile for SERENATIS BIO LIMITED (15944501), an active company based in Cambridge, England. Incorporated 9 Sept 2024. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Oct → 30 Sept 2025
Type micro-entity
Next accounts 30 Sept 2026
Due by 30 Jun 2027 12 months remaining

Net Assets, Total Assets & Total Liabilities (2025–2025)

Cash in Bank

N/A

Net Assets

£781.75k

Total Liabilities

£34.24k

Turnover

N/A

Employees

2

Debt Ratio

4%

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Sept Year End
P&L
Revenue
£142.3M
Gross Profit
£48.2M
Operating Profit
£22.4M
Net Profit
£18.1M
EBITDA
£31.5M
Assets
Cash
£24.7M
Total Assets
£89.4M
Liabilities
Total Liabilities
£45.2M
Key Metrics
Employees
1,247
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 39,546 Shares £1.00m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
15 Jun 20255,649£150k£26.55
12 May 202522,598£600k£26.55
12 May 202511,299£250k£22.13

Officers

Officers

3 active
Status
David John CavallaDirectorBritishEngland679 Sept 2024Active
Natalie PankovaDirectorBritishEngland379 May 2025Active
Nicolas Thierry SireauDirectorBritishEngland539 Sept 2024Active

Shareholders

Shareholders (8)

Nicolas Sireau
43.0%
60,000
David Cavalla
28.7%
40,000

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Nicolas Thierry Sireau

British

Active
Notified 9 Sept 2024
Residence England
DOB June 1973
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent,right To Appoint And Remove Directors

David John Cavalla

British

Active
Notified 9 Sept 2024
Residence England
DOB September 1958
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
3 Dec 2025AccountsAnnual accounts made up to 30 Sept 2025
9 Sept 2025Confirmation StatementConfirmation statement made on 8 Sept 2025 with updates
9 Sept 2025Persons With Significant ControlChange to Dr Nicolas Thierry Sireau as a person with significant control on 8 Jul 2025
8 Jul 2025CapitalAllotment of shares (GBP 1.39546) on 27 Jun 2025
24 Jun 2025AddressChange Registered Office Address Company With Date Old Address New Address
3 Dec 2025 Accounts

Annual accounts made up to 30 Sept 2025

9 Sept 2025 Confirmation Statement

Confirmation statement made on 8 Sept 2025 with updates

9 Sept 2025 Persons With Significant Control

Change to Dr Nicolas Thierry Sireau as a person with significant control on 8 Jul 2025

8 Jul 2025 Capital

Allotment of shares (GBP 1.39546) on 27 Jun 2025

24 Jun 2025 Address

Change Registered Office Address Company With Date Old Address New Address

Recent Activity

Latest Activity

Annual accounts made up to 30 Sept 2025

6 months ago on 3 Dec 2025

Confirmation statement made on 8 Sept 2025 with updates

9 months ago on 9 Sept 2025

Change to Dr Nicolas Thierry Sireau as a person with significant control on 8 Jul 2025

9 months ago on 9 Sept 2025

Allotment of shares (GBP 1.39546) on 27 Jun 2025

11 months ago on 8 Jul 2025

Change Registered Office Address Company With Date Old Address New Address

11 months ago on 24 Jun 2025